Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Replacement in Aneurysmal Subarachnoid Hemorrhage
NCT02350335Completed
- Sponsor
- Oslo University Hospital
- Start
- Jan 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nicotine in aneurysmal subarachnoid hemorrhage (SAH) (3 arms), sponsored by Oslo University Hospital. Primary endpoint: Cerebral vasospasm at 21 days. Started Jan 2011; status: completed.
02
Drugs
nicotine
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT02350335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350335.